Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
暂无分享,去创建一个
[1] Nilanjan Chatterjee,et al. Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database , 2002, Breast Cancer Research and Treatment.
[2] R. Tarone,et al. The greater impact of menopause on ER– than ER+ breast cancer incidence: a possible explanation (United States) , 2002, Cancer Causes & Control.
[3] J. Potter,et al. The shape of age–incidence curves of female breast cancer by hormone-receptor status , 1999, Cancer Causes & Control.
[4] I. Henderson,et al. The relationship between prognostic and predictive factors in the management of breast cancer , 2004, Breast Cancer Research and Treatment.
[5] Ahmedin Jemal,et al. Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.
[6] S. Narod. Modifiers of risk of hereditary breast and ovarian cancer , 2002, Nature Reviews Cancer.
[7] J. Peto,et al. Genetics and the common cancers. , 2001, European journal of cancer.
[8] J. Peto,et al. High constant incidence in twins and other relatives of women with breast cancer , 2000, Nature Genetics.
[9] R. Elledge,et al. Tumor characteristics and clinical outcome of elderly women with breast cancer. , 2000, Journal of the National Cancer Institute.
[10] A. Buzdar,et al. Inflammatory breast carcinoma incidence and survival , 1998, Cancer.
[11] D. Wilke,et al. Inflammatory breast carcinoma: comparison of survival of those diagnosed clinically, pathologically, or with both features. , 1998, The American surgeon.
[12] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[13] M. Seller,et al. Unusual case of Smith-Lemli-Opitz syndrome "type II". , 1995, American journal of medical genetics.
[14] D. Allred,et al. Breast cancer outcome and predictors of outcome: are there age differentials? , 1994, Journal of the National Cancer Institute. Monographs.
[15] M. Pike,et al. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.
[16] G. Clark. The biology of breast cancer in older women. , 1992, Journal of gerontology.
[17] A Morabia,et al. Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. , 1992, International journal of epidemiology.
[18] S. Romain,et al. Inflammatory carcinoma of the breast. , 1992, European journal of gynaecological oncology.
[19] W. Donegan,et al. Combined therapy for inflammatory breast cancer. , 1990, Archives of surgery.
[20] L. R. Hill,et al. Inflammatory breast carcinoma: A distinct entity? , 1985, Journal of surgical oncology.
[21] P. Levine,et al. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. , 1985, Journal of the National Cancer Institute.
[22] A. Cooperman,et al. Inflammatory breast cancer. , 1985, The Surgical clinics of North America.
[23] C. Perez-Mesa,et al. Inflammatory carcinoma of the breast , 1978, Cancer.
[24] S. Saltzstein,et al. Clinically occult inflammatory carcinoma of the breast , 1974, Cancer.
[25] P. Rosen,et al. Inflammatory carcinoma of the breast. , 1938, The Surgical clinics of North America.
[26] J. Peto,et al. Asymptotically Efficient Rank Invariant Test Procedures , 1972 .
[27] D. Cox. Regression Models and Life-Tables , 1972 .